Introduction
The vascular system is one of the first organs to form in the developing mammalian embryo. During the early stages of vascular development, endothelial cell (EC) precursors differentiate and coalesce into a primitive network of undifferentiated blood vessels in the process of vasculogenesis. In the later stages of vascular development, this primary vascular plexus is remodeled into a network of large and small vessels by the process of angiogenesis (Carmeliet, 2000; Risau, 1997) . This process is controlled by various signaling molecules and their downstream pathways. These pathways include vascular endothelial growth factor (VEGF) and its receptors, transforming growth factor-b (TGF-b) and its receptors, angiopoietin 1 and its receptor Tie2, and ephrin-B ligands and EphB receptors (Carmeliet et al., 1996; Suri et al., 1996; Wang et al., 1998) .
The Notch signaling pathway is an evolutionarily conserved signaling mechanism essential for proper embryonic development in almost all vertebrate organs. Mammals express four Notch receptors (Notch1-4) and five ligands [Jagged (Jag) 1 and 2, and Delta-like (Dll) 1, 3 and 4] (Gridley, 2007;  0925-4773/$ -see front matter Ó 2013 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mod.2013.07.001 Kageyama et al., 2005 Kageyama et al., , 2007 . Notch is a transmembrane protein and activated by its ligands, Dll or Jag proteins. Upon activation, the intracellular domain (ICD) of Notch is cleaved off and transferred into the nucleus, where the Notch ICD forms a complex with the DNA-binding protein RBP-J. This complex induces expression of Hes genes (Kageyama et al., 2008a,b) . The analysis of targeted mouse mutants has demonstrated roles of the Notch signaling pathway in embryonic vascular development. In mice, the absence of Notch signaling results in a similar phenotype characterized by defective vascular remodeling in the extraembryonic yolk sac, placenta, and embryo proper (Alva and Iruela-Arispe, 2004; Gridley, 2007) . These embryos also exhibited a loss of expression of arterial markers in arterial vessels. Notch signaling regulates the specification of arterial fate in ECs during mouse embryogenesis (Alva and Iruela-Arispe, 2004; Gridley, 2007) .
The bHLH genes Hes1 and Hes5 are essential effectors for Notch signaling, which regulate the maintenance of progenitor cells and the timing of their differentiation in various tissues and organs (Hatakeyama et al., 2004 (Hatakeyama et al., , 2006 Hojo et al., 2008 Hojo et al., , 2000 Ohtsuka et al., 1999) . These features of Hes genes have been reported especially in the development of the nervous system. However, only a few in vitro studies have shown a role of Hes genes as a downstream effecter of Notch in ECs. In vitro studies using human arterial ECs have supported that Hes1 is a downstream effector of Notch1 in the vasculature similarly as in other tissues (Albig et al., 2008; Liu et al., 2006; Quillard et al., 2008) . In humans and mice, the Notch3-Hes5 signaling pathway is crucial for the development of pulmonary arterial hypertension (Li et al., 2009 ). However, no study using Hes mutant mice has so far shown a role of Hes genes in vascular development.
The bHLH genes Hesr (Hey, HRT, gridlock, or CHF) belong to a related but different subclass from Hes genes (Fischer and Gessler, 2003) . The knockout (KO) of Hesr2 revealed a critical function during heart development with ventricle septum defect, persistent foramen ovale, tricuspid valve stenosis, and cardiomyopathy as the predominant anomalies. However, Hesr2 KO mice did not show vascular defects, in contrast to mutants of zebrafish gridlock, a homolog of Hesr2, which exhibit coarctation of the aorta (Fischer et al., 2004; Kokubo et al., 2005) . In addition, Hesr1 KO mice showed no obvious phenotype. However, mouse embryos lacking both Hesr1 and Hesr2 are embryonic lethal due to cardiovascular malformations, and have a single large ventricle and arterial differentiation defect, suggesting that Hesr1 and Hesr2 are required in mediating Notch signaling in the developing cardiac and vascular systems (Fischer et al., 2004; Kokubo et al., 2005) .
Although mutations in human Notch3 cause CADASIL, a hereditary vascular dementia, Notch3 KO mice develop normally (Joutel et al., 1996; Krebs et al., 2003) . In adult Notch3 KO mice, cerebral arteries are enlarged and have thinner smooth muscle cell (SMC) coat (Domenga et al., 2004) . Although it is expected that the Notch pathway have an important role in vascular development of the brain, Notch signaling-deficient mice have so far not been examined in detail in the head region. Here, we show that Hes1 and Hes5 regulate vascular remodeling of the brain during embryogenesis by analyzing Hes-mutant mouse embryos. We also show that Hes1 and Hes5 play a role in establishing arterial cell fate and identity of ECs of cerebral blood vessels.
Results

Hes-mutant embryos exhibit abnormal brain vascular development
We first examined Hes1 expression in the internal carotid artery of mouse embryos by in situ hybridization (ISH). Hes1 was expressed in almost all ECs of the developing internal The surface of the mesencephalon is shown. In Hes1; Hes5 DKO mice, large major branches of the internal carotid artery were decreased in number, and instead, small branches were increased (D and E) compared with the control (C). Moreover, in double-mutant mice, abnormal microvascular networks and vascular malformations (abnormal angiomas, indicated by arrows) were also observed (E). (F and G) Immunostaining for PECAM-1 (red) and Tuj1 (green) on sections through the forebrain of E10.5 control (F) and Hes1; Hes5 DKO (G) embryos. Small fragmented vessels (arrows) were observed in the neural tube of Hes1; Hes5 DKO embryos (G) compared with the control (F). Bars, 50 lm (A, F and G); 200 lm (C and D); 100 lm (E).
carotid artery at E10.5 (Fig. 1A) , suggesting that Hes1 plays a role in brain vascular development. To reveal the role of Hes genes in brain vascular development, we decided to examine Hes-mutant mice. Because it has been reported that Hes5 compensate Hes1 during the development of various organs, we examined Hes5 expression in the internal carotid artery by ISH, but Hes5 was not detectable in ECs of the developing internal carotid artery in both wild type and Hes1 KO embryos. However, it has been reported that Hes5, which was not detected in ECs of the aorta, was highly induced after genetic deletion of Hes1 (Guiu et al., 2013) , we examined both Hes1 KO and Hes1; Hes5 double knockout (DKO) embryos to understand the role of Hes genes in cerebral vascular development (Hatakeyama et al., 2004 (Hatakeyama et al., , 2006 Kita et al., 2007; Ohtsuka et al., 1999) . In almost half of Hes1 KO (data not shown) and Hes1; Hes5 DKO (Fig. 1B) embryos, hemorrhage was observed in the cerebrospinal nervous system, suggesting that Hes1 and Hes5 may play a role in brain vascular development.
To investigate the patterning of the vasculature in Hes-mutant embryos, we performed whole-mount immunostaining for the endothelial marker platelet-endothelial cell adhesion molecule (PECAM)-1. In E10.5 Hes1 KO embryos, abnormal microvascular networks were observed over the brain compared with the control, but this phenotype was not obvious probably owing to compensation by Hes5 (data not shown). In Hes5 KO embryos, there was no phenotype in vascular development (data not shown). Interestingly, in E10.5 Hes1; Hes5 DKO embryos, the number of large branches of the internal carotid artery was decreased, and instead, the number of small branches was increased compared with the control (Fig. 1C and D ). Abnormal microvascular networks over the brain were also observed in Hes1; Hes5 DKO mice (Fig. 1E ). In Hes1; Hes5 DKO embryos, vascular malformations (abnormal angiomas) were also observed in the brain (Fig. 1E, arrows) . Next, in order to examine these abnormal microvascular networks in more detail, we performed immunostaining for PE-CAM-1 and Tuj1 on sections through the forebrain of E10.5 Hes1; Hes5 DKO embryos. In Hes1; Hes5 DKO embryos, many small fragmented vessels were observed in the neural tube ( Fig. 1G , arrows) compared with the control (Fig. 1F ). Because it takes time for the formation of secondary vascular malformations due to cerebral hemorrhage, it is considered unlikely that brain hemorrhage leads to vascular malformations in mouse embryos. Therefore, these abnormal vessels and angiomas may be the cause of hemorrhage in the nervous system of Hes mutant embryos. These phenotypes can be explained by defective remodeling of the primary vascular plexus of the brain. These data suggest that Hes1 and Hes5 regulate vascular remodeling in brain vascular development during embryogenesis of mice.
Generation of conditional Hes1; Hes5 double knockout mice
It has previously been shown that the size, shape and cytoarchitecture of the central nervous system are severely disorganized in Hes1; Hes5 DKO mice, because neural stem cells are prematurely depleted without giving rise to later-born cell types such as astrocytes and ependymal cells (Hatakeyama et al., 2004) . Therefore, we cannot dismiss the possibility that this disruption of neural tube structures may account for the phenotypes of cerebral blood vessels in Hes1; Hes5 DKO embryos. To exclude this possibility, we generated endothelialspecific Hes1 conditional knockout (cKO) mice by crossing Hes1 floxed mice and TIE2Cre mice (Imayoshi et al., 2008; Koni et al., 2001 ). The Tie2 gene encodes an angiopoietin receptor, a member of the receptor tyrosine kinase family, which is expressed in ECs throughout development (Koni et al., 2001 ). Because Hes5 KO mice are apparently normal, we generated Hes1 cKO mice on a Hes5-null background (Hes1; Hes5 cKO mice).
To examine the Cre recombinase activity in the developing ECs of TIE2Cre mice, we crossed these mice with ROSA26 reporter mice (Soriano, 1999) . Cre recombinase activity was detected in ECs of blood vessels in the whole body including the head (data not shown). To show the evidence of Hes1 ablation in ECs of Hes1; Hes5 cKO mice, ISH of Hes1 was performed. No Hes1 expression was detected in ECs of the internal carotid artery, but Hes1 was expressed normally in the neural tube in Hes1; Hes5 cKO embryos ( Fig. 2A and B) . Next, to show that the nervous system develops normally in Hes1; Hes5 cKO mice, we performed whole-mount immunostaining for the neuronal marker neurofilament. No phenotype was detected in the developing nervous system of Hes1; Hes5 cKO embryos ( Fig. 2C and D) . Therefore, we decided to analyze Hes1; He5 cKO mice in order to investigate the roles of Hes1 and Hes5 in brain vascular development. 
2.3.
Hes1 and Hes5 regulate vascular remodeling of the brain during embryogenesis
To investigate the patterning of the cerebral vasculature in Hes1; Hes5 cKO embryos, we performed whole-mount immunostaining for PECAM-1 (Fig. 3A-D) . In E10.5 Hes1; Hes5 cKO mice, the number of large branches of the internal carotid artery was significantly decreased, and instead, the number of small branches was significantly increased compared with the control (Fig. 3A-F) . The term ''large branches'' means arterial branches, which are more than one-half the diameter of the parent artery, and the term ''small branches'' means arterial branches, which are less than one-half the diameter of the parent artery. Abnormal microvascular networks were also observed over the brain of Hes1; Hes5 cKO embryos. These results recapitulated the vascular phenotype of global Hes1; Hes5 DKO embryos, and showed that vascular remodeling was affected in the brain of Hes1; Hes5 cKO embryos. In addition, in Hes1; Hes5 cKO mice, the internal carotid artery had a significantly increased diameter compared with the control (Fig. 3A , B and G), and the mechanism of this phenotype will be discussed in the next Section (2.4).
Next, we examined cross sections of Hes1; Hes5 cKO embryos stained for PECAM-1 in order to investigate the abnormal microvascular network of the brain in more detail. In Hes1; Hes5 cKO mice, many small fragmented vessels were observed in the neural tube compared with the control (Fig. 4A and B) . Although not statistically significant, the number of fragmented vessels tended to increase in Hes1; Hes5 cKO embryos compared with the control (Fig. 4C) . In addition, PECAM-1 positive area of fragmented vessels was significantly decreased in Hes1; Hes5 cKO embryos compared with the control (Fig. 4D) . These findings are consistent with the abnormal microvascular network in the brain of Hes1; Hes5 cKO embryos. Taken together, these data suggest that Hes1 and Hes5 regulate vascular remodeling in the brain development.
Hes1 and Hes5 regulate arterial specification of ECs of brain blood vessels
Previous studies in zebrafish and mice have shown that Notch signaling is essential for arterial versus venous cell fate decisions. Therefore, we examined the expression of CD44, an arterial endothelial marker, in E10.5 Hes1; Hes5 cKO embryos to assess vascular lineage and identity ( Fig. 4A and B) (Fischer et al., 2004; Krebs et al., 2004) . Internal carotid arteries were positive for CD44 both in Hes1; Hes5 cKO mice and the control (Fig. 5A and B, arrows) . However, CD44 pisitive ECs were not detected in blood vessels of the neural tube of Hes1; Hes5 cKO embryos (Fig. 5B) , although CD44 positive ECs were faintly detected in the neural tube of the control (Fig. 5A,  arrowhead) . This suggests that Hes1 and Hes5 control the arterial cell fate specification of ECs in the head region.
The maturation of blood vessels requires the formation of vascular smooth muscle cells (vSMCs) around the nascent endothelial tube. This process occurs earlier in arteries than in veins, and is regulated by signaling from ECs to the surrounding differentiating vSMCs (Carmeliet, 2000; Winkler et al., 2011) . Therefore, we examined the expression of a (A-D) Whole-mount PECAM-1-stained control (A and C) and Hes1; Hes5 cKO (B and D) embryos at E10.5. In Hes1; Hes5 cKO embryos, large branches of the internal carotid artery were decreased in number (A and B, white dots indicate branch points of large branches), and instead, small branches were increased compared with the control (C and D, red dots indicate branch points of small branches). The term ''large branches'' means arterial branches, which are more than one-half the diameter of the parent artery, and the term ''small branches'' means arterial branches, which are less than one-half the diameter of the parent artery. Abnormal microvascular networks were also observed in the brain of Hes1; Hes5 cKO embryos. Furthermore, in Hes1; Hes5 cKO mice (B), the diameter of the internal carotid artery (brackets) was larger than in the control mice (A). (E) Quantification of branch points of large branches. Ten cerebral hemispheres obtained from 5 independent embryos were examined for each genotype. Large major arterial branches were significantly decreased in Hes1; Hes5 cKO mice compared with the control (p < 0.0001, t-test). (F) Quantification of branch points of small branches. Ten cerebral hemispheres obtained from 5 independent embryos were examined for each genotype. Small arterial branches were significantly increased in Hes1; Hes5 cKO mice compared with the control (p < 0.02, t-test). (G) Quantification of the diameter of the internal carotid artery. Ten internal carotid arteries obtained from 5 independent embryos were examined for each genotype. The diameter of the internal carotid artery was significantly increased in Hes1; Hes5 cKO mice compared with the control (p < 0.02, ttest). Bars, 200 lm (A-D).
smooth muscle actin (aSMA), the earliest marker of vSMCs, in the internal carotid artery (Fig. 5C and D) (Chang et al., 2012; Domenga et al., 2004; Kokubo et al., 2005; Krebs et al., 2004) . The expression level of aSMA was significantly reduced in the internal carotid artery of Hes1; Hes5 cKO embryos ( Fig. 5C -E) compared with the control, whereas PECAM-1 expression appeared unaffected. The layer of vSMCs was affected probably due to the defective signaling from ECs in Hes1; Hes5 cKO embryos. In addition, in Hes1; Hes5 cKO mice, the diameter of the internal carotid artery was larger than in the control mice (Fig. 3A, B and G) . This abnormal layer of vSMCs may be the cause of dilatation of the internal carotid artery in Hes1; Hes5 cKO embryos (Domenga et al., 2004) . Taken together, these results show that ECs of cerebral blood vessels of Hes1; Hes5 cKO embryos have partially lost arterial identity, and that Hes1 and Hes5 play a role in establishing arterial cell fate and identity of ECs during the development of the brain.
Discussion
Hes1 and Hes5 regulate vascular remodeling in the brain during embryogenesis
Previous reports have shown that Notch1-mutant embryos exhibited deficits in angiogenic remodeling (Gridley, 2007; Krebs et al., 2000) . Although deletion of Notch4 did not affect vascular development, Notch1; Notch4 DKO embryos displayed more severe phenotypes than embryos deficient in Notch1 alone (Krebs et al., 2000) . Global deletion of Notch1 resulted in defective embryonic morphogenesis, including defects in vascular development, neurogenesis, and somitogenesis. Unexpectedly, endothelial-specific Notch1 cKO embryos displayed severe defects not only in vascular remodeling but also in tissues distinct from the vasculature (Limbourg et al., 2005) . Specifically, the forebrain neural tube in endothelial-specific Notch1 cKO mice was grossly degenerated. Therefore, vascular phenotypes of the brain of Notch1 mutant embryos could not be analyzed. Heterozygous deletion of Dll4 showed increased numbers of smaller arterial branches of the internal carotid artery, although the major arteries such as the internal carotid artery appeared normal (Gale et al., 2004 ; Suchting et al., 2007). In endothelial-specific Jag1 cKO embryos, the blood vessels in the head region were less finely branched (High et al., 2008; Xue et al., 1999) . In Hesr1; Hesr2 DKO embryos, large cranial vessels appeared truncated. However, the possibility that the defective vessel branching was secondary to the disruption of the neural tube cannot be dismissed because Hesr1; Hesr2 DKO embryos were strongly reduced in overall size (Fischer et al., 2004; Kokubo et al., 2005) . Unfortunately, this phenotype was not investigated in endothelial-specific Hesr mutant embryos (Xin et al., 2007) . Thus, the mechanism of brain vascular development has not been elucidated so far by analyzing Notch signaling-deficient mice.
In this study, we generated and analyzed endothelialspecific Hes1; Hes5 cKO mice. In Hes1; Hes5 cKO mice, neural structures were not affected and developed normally. In Hes1; Hes5 cKO mice, the number of large branches of the internal carotid artery was decreased, and instead, the number of small branches was increased. Abnormal microvascular network over the brain was also observed in Hes1; Hes5 cKO embryos. These findings show that vascular remodeling was affected in the brain of Hes1; Hes5 cKO embryos. Our data suggest that Hes1 and Hes5 represent critical transducers of Notch signals in brain vascular development.
Hes1 and Hes5 modulate arterial fate decision of ECs in brain vascular development
In Notch1 KO or Hesr1; Hesr2 DKO embryos, CD44 expression was down-regulated in the dorsal aorta, suggesting that the arterial cell fate specification of ECs is controlled by Notch1 or a combination of Hesr1 and Hesr2 (Fischer et al., 2004) . Loss of arterial markers in Notch1 KO or Hesr1; Hesr2 DKO embryos occurs specifically in the dorsal aorta. Although endothelial-specific RBPJ cKO embryos also exhibited the same phenotype, brain blood vessels were not examined in this mutant embryo . In our study, CD44-pisitive ECs were decreased in the neural tube of Hes1; Hes5 cKO embryos, although the internal carotid artery was positive for CD44 both in Hes1; Hes5 cKO mice and the control. This result suggests that Hes1 and Hes5 play a role in establishing arterial cell fate or identity in brain vascular development.
In Hes1; Hes5 cKO embryos, Hes1 was ablated only in ECs, but not in adjacent vSMCs. However, the expression level of aSMA was reduced around ECs of the internal carotid artery. This result shows that endothelial-specific deletion of Hes1 and Hes5 resulted in a marked reduction of vSMCs, suggesting that Hes1; Hes5 double-null ECs were defective in signaling, such as platelet derived growth factor (PDGF)-B, TGF-b, and angiopoietin to adjacent SMC precursors to promote their differentiation (Winkler et al., 2011) . It has been reported that endothelial loss of RBPJ resulted in down-regulation of TGFb2, and that knockdown of Notch1 inhibited cyclic straininduced angiopoietin1 expression in ECs (Copeland et al., 2011; Morrow et al., 2007) . These previous reports may support our idea described above. This also suggests that ECs of brain blood vessels of Hes1; Hes5 cKO embryos have partially lost arterial identity, and that Hes1 and Hes5 play a role in establishing arterial cell fate and identity of ECs in brain vascular development. By contrast, in the endothelial-specific Jag1 cKO embryos, the expression of SMC markers was severely diminished, although Notch signaling in ECs remained intact and the arterial specification of ECs was also normal in the absence of Jag1 (High et al., 2008) . The primary role of endothelial Jag1 is to potentiate the development of neighboring vSMCs. Endothelial Jag1 is considered to signal directly to Notch receptors on adjacent vSMCs. Thus, Hes1 and Jag1 may be involved in the development of vSMCs in a completely different mechanism, although it is not possible to confirm this idea, because we could not examine Jag1 in Hes1; Hes5 cKO mice.
Taken together, our data suggest that Hes1 and Hes5 control the arterial cell fate specification of EC precursors in brain vascular development.
Possible roles of Hes1 and Hes5 in cerebrovascular disease
Arteriovenous malformations (AVMs) of the central nervous system are congenital disorders resulting from aberrant differentiation of the mesoderm during embryonic development, leading to lesions that bear morphological resemblance to the early anastomotic plexuses formed during central nervous system vascular embryogenesis Takagi et al., 2006) . Although intracranial AVMs are recognized as a cause of stroke, the mechanism of their development and enlargement is still unclear. In mice, Dll4 +/À , Notch1 KO and endothelial-specific RBPJ cKO embryos exhibited AVMs in the body, which were caused by fusion of the dorsal aorta and the common cardinal vein (Krebs et al., , 2010 . However, brain AVMs were not detected in these mutant mice. In our study, Hes1; Hes5 DKO embryos exhibited vascular malformations in the brain, although we did not show the direct shunt flow in these lesions. Interestingly, mouse embryos with conditional activation of the Notch1 gene in ECs also exhibited AVMs in the body (Krebs et al., 2010) . The inducible expression of an activated Notch4 transgene in adult mice results in vessel arterialization, and causes AVMs in several organs, including liver, uterus, skin and brain (Carlson et al., 2005; Murphy et al., 2008) . In induced brain AVMs of these transgenic mice, Hes1 signal was increased in ECs (Murphy et al., 2009) . In human brain AVMs, the analysis of surgical specimens has shown that the expression of Hes1 and Notch1 was increased (ZhuGe et al., 2009) . Both the loss of function and gain of function Notch1 mutant embryos had AVMs in the body. Formation of AVMs during embryonic development is likely due to an inability of the vascular beds to maintain distinct arterial and venous identities (Krebs et al., 2010) . Therefore, it is considered that Hes1 expression in human brain AVMs and mouse induced AVMs is consistent with the phenotype of Hes1; Hes5 cKO mice. Taken together, Hes1 and Hes5 may play a role in the formation of vascular malformations in the brain.
In summary, Hes1 and Hes5 control angiogenic remodeling and the arterial cell fate specification of EC precursors in brain vascular development. Hes1 and Hes5 represent critical transducers of Notch signals in brain vascular development.
In addition, Hes1 and Hes5 may play a role in the formation of brain vascular malformations.
4.
Experimental procedures
Mice
TIE2Cre mice were a gift from Pandelakis A. Koni (Koni et al., 2001 Hes1 and Hes5 mutant, and Hes1 floxed mice were determined as previously described (Cau et al., 2000; Hirata et al., 2001; Kita et al., 2007; Koni et al., 2001 ). All analyses were performed between littermates. Hes1 +/fl ; Hes5 À/À mice were found to have no significant phenotype in the developing vascular system and were therefore used as controls. For analysis of Cre recombinase activity, TIE2Cre mice were crossed with ROSA26 reporter mice (a gift from P. Soriano) and analyzed by X-gal staining as previously described (Imayoshi et al., 2010; Soriano, 1999 ).
In situ hybridization
Digoxigenin-labeled antisense RNA probes corresponding to fragments of Hes1 cDNAs were synthesized in vitro. In situ hybridization was performed as previously described (Hirata et al., 2001; Hojo et al., 2000; Kita et al., 2007) . Briefly, 16-lmthick cryosections were treated with proteinase K, refixed with 0.2% glutaraldehyde and 4% paraformaldehyde, washed with 0.1% Tween 20 in PBS, and hybridized with RNA probe in 50% formamide, 5· SSC, 1% SDS, 50 lg/ml heparin, and 50 lg/ ml tRNA solution at 65°C overnight. After hybridization, sections were washed at 65°C in 50% formamide, 5· SSC, 1% SDS, treated with ribonuclease, washed in 50% formamide, and 2· SSC, washed in Tris-buffered saline, and incubated with alkaline-phosphatase-conjugated antibody against digoxigenin at 4°C overnight. After incubation, the sections were washed with 0.1% Tween 20 in Tris-buffered saline three times, and in 100 mM NaCl, 100 mM Tris-HCl, pH 9.5, 50 mM MgCl 2 , and 0.1% Tween 20 solution once. For a color development reaction, 4-nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate (BCIP) were used as substrates. Labeled preparations were imaged using a Carl Zeiss Axiophoto microscope equipped with a CCD camera.
4.3.
Whole-mount immunostaining
Embryos were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS) at 4°C for 3 h and were bleached with 0.1% H 2 O 2 at 4°C for 16 h. Then, the embryos were incubated in anti-PECAM or anti-neurofilament antibody solutions [antibody was diluted at 1/2 in TS-PBS (1% Triton X-100; 10% FBS in PBS)] at 4°C for 3 days and next with peroxidase (Chemicon) or Alexa 594 (Molecular Probes) -conjugated secondary antibodies overnight at 4°C. The peroxidase deposits were visualized by 4-chloro-1-naphthol (Hatakeyama et al., 2006) .
Immunostaining
Immunostaining was performed with the following antibodies: rat anti-PECAM (BD Pharmingen), mouse anti-aSMA (Sigma), mouse anti-Tuj1 (Covance), and rat anti-CD44 (BD Pharmingen) antibodies. Cryosections were incubated in 5% normal goat serum and 0.1% Triton X-100 at room temperature for 1 h, then incubated with primary antibodies at 4°C overnight (Hojo et al., 2000; Kita et al., 2007) . Donkey or goat anti-species IgG conjugated with Alexa 488 or Alexa 598 (Molecular Probes) was used for a secondary antibody. For all antibodies, no significant signal was detected in negative controls. Sections were analyzed with LSM510 confocal microscopy (Carl Zeiss).
